|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations 显示文摘 | Nordsmark M Alsner J Keller J | 2001 | Br J Cancer2001，84，8： | 2 |
| 2 | Differential risk asse- ssments from five hypoxia specific assays: The basis for biologi- cally adapted individualized radiotherapy in advanced head an- d neck cancer patients显示文摘 | Nordsmark M Eriksen JG Gebski V | 2007 | Radiother Oncol2007，83，3： | 1 |
| 3 | A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cellcarcinoma treated by radiation therapy显示文摘 | Nordsmark M Overgaard J | 2000 | Radiother Oncol2000，57，1： | 1 |
| 4 | Characteriza-tion of positron emission tomography hypoxia tracer uptake and tis-sue oxygenation via electrochemical modeling显示文摘 | Bowen SR van der Kogel AJ Nordsmark M | 2011 | Nucl Med Biol2011，38，6： | 1 |
| 5 | Plasma osteopontin, hypoxia, and response to the hypoxia sensitisernimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial 显示文摘 | Overgaard J Eriksen JG Nordsmark M | 2005 | Lancet Onco12005，6，： | 1 |
| 6 | The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study显示文摘 | Nordsmark M Loncaster J Aquino-Parsons C | 2006 | Radiother Oncol2006，80，2： | 1 |
| 7 | Differential risk assessments from five hypoxia specific assays:The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients显示文摘 | Nordsmark M Eriksen JG Gebski V | 2007 | Radiother Oncol2007，83，3： | 1 |
| 8 | Measurement of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas 显示文摘 | Nordsmark M Loncaster J Aquino-Parsons C | 2003 | Radiother Oncol2003，67，1： | 1 |
| 9 | Plasma os- teopontin,hypoxia,and response to the hypoxia sensitiser ni- morazole in radiotherapy of head and neck cancer Results from the DAHANCA 5 randomised double-blind placebo con- trolled trial显示文摘 | Overgaard J Eriksen J G Nordsmark M | 2005 | Lancet Oncol2005，6，10： | 1 |
| 10 | A confirmatory prog-nostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy 显示文摘 | Nordsmark M Overgaard J | 2000 | Radiother Oncol2000，57，1： | 1 |
| 11 | Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients 显示文摘 | NORDSMARK M ERIKSEN JG GEBSKI V | 2007 | Radiother Oncol2007，83，3： | 1 |
| 12 | Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double - blind placebo - controlled trial显示文摘 | OVERGAARD J ERIKSEN J G NORDSMARK M | 2005 | Lancet Oncol2005，6，10： | 1 |
| 13 | Differenti- al risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radio- therapy in advanced head and neck cancer patients显示文摘 | Nordsmark M Eriksen J G Gebski V | 2007 | Radiother Oncol2007，83，3： | 1 |
| 14 | A confirmatory prognostic study on oxygenation status and loco-regional control in advance head and neck squamous cell carcinoma treated by radiation therapy 显示文摘 | Nordsmark M Overgaard J | 2000 | Radiother Oncol2000，57，： | 1 |
| 15 | The prognostic value of serum osteopontin,HIF-1alpha and p(O)2 measurements in a-dvanced head and neck tumors treated by radiotherapy显示文摘 | Nordsmark M Alsner J Eriksen JG | 2003 | Eur J Cancer Suppl2003，1，5： | 1 |
| 16 | Development of a hypoxia gene expression classifier with predictive impact for hy- poxic modification of radiotherapy in head and neck cancer显示文摘 | Tonstrup K Sorensen BS Nordsmark M | 2011 | Cancer Res2011，71，17： | 1 |
| 17 | Plasma osteopon-tin,hypoxia,and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer:results from the DAHANCA 5 randomised double-blind placebo-controlled trial显示文摘 | Overgaard J Eriksen JG Nordsmark M | 2005 | Lancet Oncol2005，6，10： | 1 |
| 18 | Hypoxia in human soft tissue sarcomas:adverse impact on survival and no association with p53 mutations显示文摘 | Nordsmark M Alsner J Keller J | 2001 | Br J Cancer2001，84，8： | 1 |
| 19 | Plasma osteopontin,hypoxia,and response to the hypoxia sensitiser nimorazole in radioth-erapy of head and neck cancer:results from the DAHANCA 5 randomised double-bind placcbo-controlled trial显示文摘 | Overgaard J Eriksen JG Nordsmark M | 2005 | Lancet Oncol2005，6，10： | 1 |
| 20 | Increased intra- tumoral FOXP3 - positive regulatory immune cells during interleukin- 2 treatment in metastatic renal cell carcinoma 显示文摘 | Jensen HK Donskov F Nordsmark M | 2009 | Clin Cancer Res2009，15，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员